Mercury Labs

{
  "main_header": {
    "sid": 287757,
    "name": "Mercury Labs",
    "stock_name": "Mercury Labs",
    "full_name": "Mercury Laboratories Ltd",
    "name_url": "stocks-analysis/mercury-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "700.00",
    "chg": -30,
    "chgp": "-4.11%",
    "dir": -1,
    "prev_price": "730.00",
    "mcapval": "88.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538964,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE947G01011",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "378 ",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mercury-labs-287757-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mercury Laboratories Ltd Falls to 52-Week Low of Rs 700.05 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3924297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3924297.png",
        "date": "2026-03-30 10:38:29",
        "description": "For the third consecutive session, Mercury Laboratories Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 700.05 on 30 Mar 2026. This marks an 18.12% drop over the last three days, underscoring persistent selling pressure despite some positive financial indicators."
      },
      {
        "title": "Mercury Laboratories Ltd Downgraded to Strong Sell Amid Bearish Technicals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-downgraded-to-strong-sell-amid-bearish-technicals-and-weak-fundamentals-3923522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_mojoScore_3923522.png",
        "date": "2026-03-30 08:05:43",
        "description": "Mercury Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 Mar 2026. This shift reflects a deterioration in technical indicators alongside persistent fundamental weaknesses, despite some recent positive financial results. The company’s stock price has also suffered a sharp decline, underscoring investor caution amid mixed signals."
      },
      {
        "title": "Five Consecutive Losses Push Mercury Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-falls-to-52-week-low-of-rs730-3919609",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3919609.png",
        "date": "2026-03-27 12:38:14",
        "description": ""
      },
      {
        "title": "Mercury Laboratories Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-upgraded-to-sell-on-technical-improvements-and-valuation-appeal-3898081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_mojoScore_3898081.png",
        "date": "2026-03-18 08:05:04",
        "description": "Mercury Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators amid mixed financial and valuation metrics. While the company’s recent quarterly performance shows promising growth, long-term fundamentals remain weak, prompting a cautious stance from analysts."
      },
      {
        "title": "Mercury Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-strong-sell-3892024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_mojoScore_3892024.png",
        "date": "2026-03-15 10:10:32",
        "description": "Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 26 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Mercury Laboratories Ltd Stock Falls to 52-Week Low of Rs.770",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-falls-to-52-week-low-of-rs770-3879937",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3879937.png",
        "date": "2026-03-09 12:12:15",
        "description": "Mercury Laboratories Ltd has declined to a fresh 52-week low of Rs.770, marking a significant downturn in its stock performance amid broader market weakness and sectoral underperformance. The stock’s fall reflects a combination of subdued long-term growth metrics and recent trading volatility."
      },
      {
        "title": "Mercury Laboratories Ltd Stock Falls to 52-Week Low of Rs.775",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-falls-to-52-week-low-of-rs775-3875849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3875849.png",
        "date": "2026-03-06 10:36:04",
        "description": "Mercury Laboratories Ltd has touched a new 52-week low of Rs.775 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance trends. The stock underperformed its sector and continues to trade below all major moving averages, reflecting ongoing challenges in maintaining upward momentum."
      },
      {
        "title": "Mercury Laboratories Ltd Stock Falls to 52-Week Low of Rs.775",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-falls-to-52-week-low-of-rs775-3875843",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3875843.png",
        "date": "2026-03-06 10:36:00",
        "description": "Mercury Laboratories Ltd has touched a new 52-week low of Rs.775 today, marking a significant decline in its stock price amid broader sector underperformance and subdued long-term growth metrics."
      },
      {
        "title": "Mercury Laboratories Ltd Downgraded to Strong Sell Amid Technical Weakness and Long-Term Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-long-term-underperformance-3859602",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MercuryLaborato_mojoScore_3859602.png",
        "date": "2026-02-27 08:04:43",
        "description": "Mercury Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 26 Feb 2026. This revision reflects deteriorating technical indicators, subdued financial trends, and persistent valuation concerns despite some recent positive quarterly results. The downgrade highlights growing investor caution amid the company’s ongoing underperformance relative to benchmarks and peers."
      }
    ],
    "total": 125,
    "sid": "287757",
    "stock_news_url": "https://www.marketsmojo.com/news/mercury-laboratories-287757"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation of closure of Trading window for the announcement of audited finacial results for the quarter and financial year ending of March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2026",
      "details": "Submission of newspaper publication of unaudited financial results for the quarter and nine months ended on December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11.02.2026",
      "datetime": "11-Feb-2026",
      "details": "Outcome of Board Meeting held on February 11 2026 is attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mercury Laboratories Ltd has declared <strong>35%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mercury Laboratories Ltd Falls to 52-Week Low of Rs 700.05 as Sell-Off Deepens

2026-03-30 10:38:29

For the third consecutive session, Mercury Laboratories Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 700.05 on 30 Mar 2026. This marks an 18.12% drop over the last three days, underscoring persistent selling pressure despite some positive financial indicators.

Read full news article

Mercury Laboratories Ltd Downgraded to Strong Sell Amid Bearish Technicals and Weak Fundamentals

2026-03-30 08:05:43

Mercury Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 Mar 2026. This shift reflects a deterioration in technical indicators alongside persistent fundamental weaknesses, despite some recent positive financial results. The company’s stock price has also suffered a sharp decline, underscoring investor caution amid mixed signals.

Read full news article

Five Consecutive Losses Push Mercury Laboratories Ltd to a New 52-Week Low

2026-03-27 12:38:14

Read full news article

Mercury Laboratories Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal

2026-03-18 08:05:04

Mercury Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators amid mixed financial and valuation metrics. While the company’s recent quarterly performance shows promising growth, long-term fundamentals remain weak, prompting a cautious stance from analysts.

Read full news article

Mercury Laboratories Ltd is Rated Strong Sell

2026-03-15 10:10:32

Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 26 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Mercury Laboratories Ltd Stock Falls to 52-Week Low of Rs.770

2026-03-09 12:12:15

Mercury Laboratories Ltd has declined to a fresh 52-week low of Rs.770, marking a significant downturn in its stock performance amid broader market weakness and sectoral underperformance. The stock’s fall reflects a combination of subdued long-term growth metrics and recent trading volatility.

Read full news article

Mercury Laboratories Ltd Stock Falls to 52-Week Low of Rs.775

2026-03-06 10:36:04

Mercury Laboratories Ltd has touched a new 52-week low of Rs.775 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance trends. The stock underperformed its sector and continues to trade below all major moving averages, reflecting ongoing challenges in maintaining upward momentum.

Read full news article

Mercury Laboratories Ltd Stock Falls to 52-Week Low of Rs.775

2026-03-06 10:36:00

Mercury Laboratories Ltd has touched a new 52-week low of Rs.775 today, marking a significant decline in its stock price amid broader sector underperformance and subdued long-term growth metrics.

Read full news article

Mercury Laboratories Ltd Downgraded to Strong Sell Amid Technical Weakness and Long-Term Underperformance

2026-02-27 08:04:43

Mercury Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 26 Feb 2026. This revision reflects deteriorating technical indicators, subdued financial trends, and persistent valuation concerns despite some recent positive quarterly results. The downgrade highlights growing investor caution amid the company’s ongoing underperformance relative to benchmarks and peers.

Read full news article

View All News